Brief: Nicox Q1 Net Revenue At EUR 0.7 Million

Nicox SA

28/04/2022 06:46

April 28 (Reuters) - Nicox SA  NCOX.PA :
    * CASH POSITION OF EUR 42.0 MILLION AS OF DECEMBER 31, 2021
AND
EUR 35.1 MILLION AS OF MARCH 31, 2022, CONFIRMING COMPANY IS
FINANCED TO Q4 2023
    * Q1 2022 U.S. PRESCRIPTIONS FOR VYZULTA® INCREASED BY 43%
OVER Q1
2021
    * DEVELOPMENT PATHWAY FOR NCX 4251 IN DRY EYE DISEASE
CONFIRMED
FOLLOWING MEETING WITH U.S. FDA
    * NCX 470 MONT BLANCPHASE 3CLINICAL TRIAL IN GLAUCOMA AT
OVER 98%
RECRUITMENT
    * NET REVENUE FOR Q1 OF 2022 WAS EUR 0.7 MILLION (ENTIRELY
COMPOSED OF NET ROYALTY PAYMENTS)
    * AS OF MARCH 31, 2022, NICOX GROUP HAD FINANCIAL DEBT OF
EUR 20.5
MILLION

Source text for Eikon:  urn:newsml:reuters.com:*:nGNE12Ff3t
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))